Real World Development: Increasing value for patients
June 30, 2010Research and Development Kinapse, drug development
The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Contract research news in brief
June 30, 2010Research and Development CRO
Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …
Avandia probe deepens
June 29, 2010Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …
NHS trials patient payments
June 29, 2010NHS, PCT, patient
For the first time patients are to be paid directly by the NHS to allow them to choose how their …
J&J recall plant will be closed all year
June 29, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …
DPT promotes JJ Feik
June 29, 2010Manufacturing and Production DPT Laboratories, appointment, manufacturing and production
Contract development and manufacturing company DPT Laboratories has promoted JJ Feik to senior director of business development. He was previously …
Chemists find easier method for drug synthesis
June 29, 2010Manufacturing and Production manufacturing
Researchers in the US have developed a new synthetic pathway that could make the development of new pharmaceuticals quicker, cleaner …
Boehringer cheered by diabetes data
June 28, 2010Research and Development Boehringer, DPP-4, diabetes, linagliptin
Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …
Digital Pharma: The smokescreen of regulation
June 28, 2010Medical Communications, Sales and Marketing Janssen, social media
When framing a story for the media it is well known in the communications community that a successful piece must …
European regulator probes ARB cancer link
June 28, 2010Sales and Marketing ARB, Amias, Aprovel, Cozaar, Diovan, Micardis
European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …
Shire’s Vpriv recommended for European approval
June 28, 2010Sales and Marketing Brinavess, Gaucher, Rapiscan, Ruconest, Shire, Sycrest
Shire has won backing from a key European regulatory committee for its new Gaucher disease orphan drug. Vpriv was one …
Actavis appoints Dr Claudio Albrecht
June 28, 2010Sales and Marketing Actavis, appointment, sales and marketing
Icelandic generics company Actavis has appointed Dr Claudio Albrecht as its new chief executive. He formerly led Ratiopharm and has …
New anti-clotting drugs: stopping the silent killers
June 28, 2010Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis
Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …
Langland and Dr Foster share top honours at Best of Health
June 25, 2010Medical Communications, Sales and Marketing Best of Health, IPA, awards
Dr Foster Intelligence and Langland were awarded the most prestigious ‘Best of Show’ awards at the 2010 IPA Best of …
Anup Shah joins Woolley Pau PR
June 25, 2010Medical Communications Woolley Pau, appointment, medical communications
Anup Shah has joined Woolley Pau PR as account director to develop the UK agency’s PR’s medical communication team. He …
Sanofi licences novel oral anti-diabetic treatment
June 25, 2010Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes
Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
NICE re-thinks arthritis guidance
June 25, 2010Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis
NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …
Digital Pharma: First pharma iPad apps
June 25, 2010Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone
The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …
WPP forms largest healthcare coms network
June 25, 2010Medical Communications CommonHealth, Ogilvy, WPP, ogilvy healthworld advertising
Global communications giant WPP has merged its Ogilvy Healthworld and CommonHealth businesses. Named Ogilvy CommonHealth Worldwide, the new entity becomes …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
